exn407
Small moleculeexperimental
Clinical trial activity
1 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 5, 2020 (NCT04565756)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
SRPK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04565756 | Phase 1/Phase 2 (Phase 2) | Nov 5, 2020 | Adelaide Eye and Retina Centre, Centre for Eye Research Australia (CERA), Exonate Limited, Lions Eye Institute, Newcastle Eye Hospital Foundation, Novotech, Strathfield Retina Clinic, Sydney Eye Hospital/Save Sight Institution, Sydney Retina Clinic & Day Surgery, ZAVe Clinical Research Management - Retinology Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Adelaide Eye and Retina Centre | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Centre for Eye Research Australia (CERA) | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Exonate Limited | For profit | 1 | 1 | 1 | 2020 |
| Lions Eye Institute | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Newcastle Eye Hospital Foundation | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Novotech | For profit | 1 | 0 | 1 | 2020 |
| Strathfield Retina Clinic | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Sydney Eye Hospital/Save Sight Institution | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Sydney Retina Clinic & Day Surgery | Academic/Hospital | 1 | 0 | 1 | 2020 |
| ZAVe Clinical Research Management - Retinology Institute | Academic/Hospital | 1 | 0 | 1 | 2020 |
10 organizations
Page 1 / 1